Adenosine mediates IL-13–induced inflammation and remodeling in the lung and interacts in an IL-13–adenosine amplification pathway
- 1 August 2003
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 112 (3) , 332-344
- https://doi.org/10.1172/jci200316815
Abstract
IL-13 is an important mediator of inflammation and remodeling. We hypothesized that adenosine accumulation, alterations in adenosine receptors, and adenosine–IL-13 autoinduction are critical events in IL-13–induced pathologies. To test this, we characterized the effects of IL-13 overexpression on the levels of adenosine, adenosine deaminase (ADA) activity, and adenosine receptors in the murine lung. We also determined whether adenosine induced IL-13 in lungs from ADA-null mice. IL-13 induced an inflammatory and remodeling response that caused respiratory failure and death. During this response, IL-13 caused a progressive increase in adenosine accumulation, inhibited ADA activity and mRNA accumulation, and augmented the expression of the A1, A2B, and A3 but not the A2A adenosine receptors. ADA enzyme therapy diminished the IL-13–induced increase in adenosine, inhibited IL-13–induced inflammation, chemokine elaboration, fibrosis, and alveolar destruction, and prolonged the survival of IL-13–transgenic animals. In addition, IL-13 was strongly induced by adenosine in ADA-null mice. These findings demonstrate that adenosine and adenosine signaling contribute to and influence the severity of IL-13–induced tissue responses. They also demonstrate that IL-13 and adenosine stimulate one another in an amplification pathway that may contribute to the nature, severity, progression, and/or chronicity of IL-13 and/or Th2-mediated disorders.Keywords
This publication has 46 references indexed in Scilit:
- Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent PathwaysJournal of Biological Chemistry, 2002
- Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damageNature, 2001
- The Use of Enzyme Therapy to Regulate the Metabolic and Phenotypic Consequences of Adenosine Deaminase Deficiency in MicePublished by Elsevier ,2000
- Transcriptional and post‐transcriptional regulation of monocyte chemoattractant protein‐3 gene expression in human endothelial cells by phorbol ester andcAMP signallingImmunology, 2000
- Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cellsJournal of Clinical Investigation, 2000
- An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2–dominated inflammatory responseJournal of Clinical Investigation, 1999
- Adenosine Deaminase-deficient Mice Generated Using a Two-stage Genetic Engineering Strategy Exhibit a Combined ImmunodeficiencyJournal of Biological Chemistry, 1998
- Airways responsiveness and development and remission of chronic respiratory symptoms in adultsThe Lancet, 1997
- Effects of (R)‐deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouseTeratology, 1992
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989